Synthesis and in silico docking study towards m-pro of novel heterocyclic compounds derived from pyrazolopyrimidinone as putative sars-cov-2 inhibitors

HIGHLIGHTS

• who: Mabrouk Horchani and collaborators from the Laboratory of Heterocyclic Chemistry, Natural and Reactivity, Medicinal Chemistry and Natural (LR ES39), Faculty of Sciences of Monastir, University of Monastir, Monastir, Tunisia , Halle, Germany have published the article: Synthesis and In Silico Docking Study towards M-Pro of Novel Heterocyclic Compounds Derived from Pyrazolopyrimidinone as Putative SARS-CoV-2 Inhibitors, in the Journal: Molecules 2022, x of 26/Nov/2021
• what: In this study in the search for therapeutic alternatives to treat COVID-19 and its recent variants the authors conducted a structurebased virtual screening using docking . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.